CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies

Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is a devastating event occurring in ~ 5% of patients treated with R-CHOP. We hypothesized that adding lenalidomide to R-CHOP (R2CHOP) may decrease the risk of CNS relapse. We analyzed records for patients with DLBCL from t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Ayed, Ayed O., Chiappella, Annalisa, Pederson, Levi, Laplant, Betsy R., Congiu, Angela Giovanna, Gaidano, Gianluca, Spina, Michele, Re, Alessandro, Cavallo, Federica, Musuraca, Gerardo, Macon, William R., Witzig, Thomas, Vitolo, Umberto, Nowakowski, Grzegorz S.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018787/
https://ncbi.nlm.nih.gov/pubmed/29946110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0097-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados